Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells. (2021)
Attributed to:
Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d1nr02179f
PubMed Identifier: 34160534
Publication URI: http://europepmc.org/abstract/MED/34160534
Type: Journal Article/Review
Volume: 13
Parent Publication: Nanoscale
Issue: 26
ISSN: 2040-3364